AstraZeneca Egypt launches first immuno-oncology summit in Cairo
Reinforcing its leadership in advancing healthcare and expanding access to evidence-based medical innovation, AstraZeneca Egypt & NEMAG launched the first edition of its Immuno-Oncology Summit, held…
Read the full articleYou might also wanna read
Pre-Clinical Models Panel Discussion at the 2026 SITC EU Immuno-Oncology Drug Development Summit
Society for Immunotherapy of Cancer shared a post on LinkedIn: “Join the Panel Discussion: Pre-Clinical Models at the 2026 SITC EU Immuno-On
Oncology R&D Strategy to Transform Cancer Care – AstraZeneca
AstraZeneca, shared a post on LinkedIn: “We have a bold ambition in oncology – to one day eliminate cancer as a cause of death. Our Oncology
FDA Immunotherapy Approvals: First Half of 2026
FDA immunotherapy approvals in the first half of 2026 demonstrate the continued evolution of cancer immunotherapy beyond conventional checkp
CancerVax Develops Novel Smart mRNA to Harness Pre-Existing Immunity in 99% of World Population
Company completes design and in-vitro validation of a single Smart mRNA that disguises cancer as multiple viral infections simultaneously to
NEOSENT: Early Anti-PD-1 Therapy In High-Risk Stage II Melanoma
Conditions : Cutaneous Melanoma Interventions : Other: Anti-PD1 Therapy Timing Sponsors : AC Camargo Cancer Center Recruiting
ASCO Day 3: Pancreatic cancer advance earns standing ovation; Akeso and Summit face disappointment
ASCO Day 3: A huge advance for pancreatic cancer, a let down for Akeso and Summit, and a new approach to immunotherapy.
statnews.com·1mo ago
Comments
Sign in to join the conversation.
No comments yet. Be the first.